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Swyer syndromeAbstract 46XY complete gonadal dysgenesis (SWYER SYNDROME) is a rare type of Disorder
of Sex Development. Herein we report a 15 years-old child, reared as female, presented with com-
plaints of primary amenorrhoea, without short stature or Turner’s stigmata. Secondary sexual
development was normal. Biochemically, luteinizing hormone (LH) was 23.29 mIU/ml and follicle
stimulating hormone (FSH) was 54.94 mIU/ml. Serum estradiol level was 15.33 pg/ml (21–51), and
Testosterone was 14.04 ng/dl. USG abdomen revealed a small uterus with thinned endometrium.
MRI Abdomen showed hypoplastic uterus with non-visualized B/L ovaries (? Complete/pure gona-
dal dysgenesis). Patient had withdrawal bleeding with estrogen progesterone challenge test.
Karyotype analysis revealed 46XY with no evidence of mosaicism. Based on these results a diagno-
sis of Swyer Syndrome (complete gonadal dysgenesis: Disorder of Sexual Development) was sus-
pected. Patient was managed with a multidisciplinary approach and various issues were discussed.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
46XY complete gonadal dysgenesis (SWYER SYNDROME)
is a rare type of Disorder of Sex Development (DSD) first
described by Gim Swyer in 1955 where a 46-XY subject pre-
sents with internal and external female genitalia, normal or lit-
tle mammary development and primary amenorrhoea, withoutclinical stigmata for Turner syndrome. It can be sporadic or
familial.1 We herein report a case of SWYER SYNDROME.
2. Case report
A 15 years old child, reared as female, born of non-
consanguineous marriage, presented to our Out-patient
Department with primary amenorrhoea (Fig. 1). The subject
had female sexual identity, with normal height and appropriate
secondary sexual characters for her age. Past medical, family,
and developmental histories were not contributory. General
and systemic examinations were within normal limits; the sub-
ject had no stigmata of Turner’s syndrome. Breast develop-
ment was appropriate for age (Tanner stage III).2 External
genitalia were normal; there was no evidence of ambiguity.
Pubic hair growth was Tanner’s stage III, and axillary hair
development was normal. Anthropometric measurements were
appropriate for age.
Figure 1 Patient’s social photograph.
2 J. Khare et al.3. Investigations
Routine biochemical and haematological investigations were
within normal limits. Karyotype analysis revealed 46XY, with-
out mosaicism. A repeat karyotype over 100 cells showed the
same result (Fig. 2). Hormonal evaluations were consistent
with primary gonadal failure: [TSH 1.59 mIU/L, Prolactin
4.49 ng/dl, LH 23.29 IU/L, FSH 54.94 mIU/ml, Testosterone
14.04 ng/dl, Oestrogen 15.33 pg/ml]. X-ray of both hands sug-
gested a bone-age of 14 years. USG abdomen revealed a small
uterus with thinned endometrium. MRI Abdomen revealed a
hypoplastic uterus; gonads were not visible bilaterally (Pure
gonadal dysgenesis).
A FISH study revealed that the proband was positive for
SRY region on Y-chromosome (Fig. 3).
4. Management
At this point, we had a 15-year old phenotypic female subject,
with primary amenorrhoea, normal external genitalia andPlease cite this article in press as: Khare J et al. Swyer syndrome: The gender swayeMullerian structures present on imaging, with spontaneous
Tanner stage III.2
The subject failed to bleed to a progesterone challenge.
Subsequently, she was started on low-dose continuous oestro-
gen priming, following which she had breakthrough bleeding.
She was then prescribed combination of oestrogens and pro-
gestogen to induce cycling bleeding. Diagnosis of DSD was
disclosed to the parents with the help of our psychological
counsellor. Parents were thoroughly educated and counselled
about DSD including Swyer syndrome in accordance with clin-
ical guidelines for the management of disorders of sex develop-
ment in childhood.3 Multiple counselling sessions were held to
slowly alleviate the initial shock and bring about acceptance of
the condition. Parents were counselled about the risk of gona-
dal tumour and were advised gonadectomy but they refused
for the same. We are following the subject every 3–6 months
in our Out-Patient Department and continue to counsel the
parents. They were counselled in detail about future fertility,
which might be achieved with donated egg or embryo as she
cannot produce eggs.5. Discussion
This 15-year old normotensive child reared as a girl came with
complaints of primary amenorrhoea and on work-up was
found to have 46XY DSD. She was positive for a functional
SRY region on her Y-chromosome on FISH study.
DSD-s are congenital conditions in which chromosomal,
gonadal, and genital sex of the subjects are not coincident.1
According to classification of DSD,1 our patient falls in Class
B [Abnormal Gonadal Differentiation (Dysgenetic DSD)]; sub
class B.I [46XY complete gonadal dysgenesis (Swyer syn-
drome)]. The most common condition leading to an XY female
is complete androgen insensitivity syndrome (CAIS) and is
also the main differential diagnosis. Phenotypically, CAIS pre-
sents with normal breast development but minimal pubic and
axillary hair. Because AMH is normally secreted by the func-
tional testes, there are no mullerian structures and the vagina is
hypoplastic.1 However, our patient had normal mullerian
structures, and so CAIS was excluded.
Swyer syndrome is a rare cause of DSD, with incidence of
1:80,000. This syndrome, first described by Swyer in 1955, is
caused by an error in sex determination during the course of
embryogenesis. Patients with Swyer syndrome present with
an incomplete or absent masculinization due to abnormalities
in the production of testosterone and Mu¨llerian-inhibiting
factor.6
Molecular and genetic abnormalities associated with Swyer
syndrome include mutations in the ARX, ATRX, CBX2,
DHH, DMRT1, GATA4, MAMLD1, MAP3K1, NR0B1,
NR5A1, SOX9, WNT4, WT1, WWOX, SRY, and WNT4
genes. The SRY gene is deleted in approximately 10–15%,
and mutated in an additional 10–15%, of patients.4,5 Most
patients first seek medical attention in adolescence for primary
amenorrhoea and/or the absence of secondary sex characteris-
tics.7 This is consistent in our patient, too, who presented with
primary amenorrhoea. Swyer syndrome patients are normal-
to-tall, present with small or undeveloped breasts, with normal
axillary and pubic hair development. The external genitalia are
typical of females. Upper part of the vagina and tubes are nor-
mal or reduced, and the uterus is small or rudimentary. Ther?, Alex J Med (2016), http://dx.doi.org/10.1016/j.ajme.2016.05.006
Figure 2 Cytogenetic analysis showing 46XY Karyotype.
Swyer syndrome 3gonads are dysgenetic strips composed of only fibrous tissue;
they do not exhibit hormonal function and gametogenesis.
The gonads are at high risk for gonadal tumours, which are
typically gonadoblastomas and/or dysgerminomas.5,7
Immunohistochemical staining, including octamer binding
transcription factor (OCT) 3/4, placental-like alkaline phos-
phatase (PLAP), b-catenin, alpha-fetoprotein (AFP), and stem
cell factor receptor CD117 (c-KIT) helps in predicting the risk
of gonadal tumours. OCT 3/4 is the most reliable marker for
the risk of malignancy. So consideration of these immunohis-
tochemical markers carefully can prevent unnecessary
gonadectomy. Expression of three markers OCT 3/4, PLAP,
and CD117 strongly suggests for gonadectomy, even in the
absence of overt germ cell malignancy.8
In patients suspected of having Swyer syndrome, labora-
tory tests for electrolytes, FSH, LH, prolactin, TSH, free T4,
SHBG, androstenedione, estradiol, and testosterone5 help in
diagnostic confirmation. In our case, FSH and LH levels were
elevated and estradiol levels were low, suggestive of hyperg-
onadotropic hypogonadism, a condition consistent with Swyer
syndrome. As a rule, Swyer syndrome patients exhibit low
androgen levels and a non-mosaic karyotype of 46XY. In addi-
tion, patients can be tested for levels of anti-Mu¨llerian hor-
mone and inhibin, although these tests are not mandatory.4Please cite this article in press as: Khare J et al. Swyer syndrome: The gender swaye6. Summary
This case report is relevant as it calls attention to exclude rare
DSD like Swyer syndrome in a subject with primary amenor-
rhoea, as accurate and early diagnosis would allow for conser-
vative treatment and appropriate psychological counselling,
which may ensure the preservation of fertility, reduce emo-
tional trauma, and improve patient survival.4
7. Limitation
Parents were asked to allow for the gonadectomy of intra-
abdominal gonads with 46XY chromosome with proper coun-
selling, but parents refused for procedure, as they were satisfied
after withdrawal bleeding. Estimation of immunohistochemi-
cal markers was not done due to cost constraints.Conflict of interest
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Figure 3 FISH analysis showing proband positive for SRY region on Y chromosome.
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